| Autor: |
Wood JM; National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire, UK. jwood@nibsc.ac.uk, Major D, Newman RW, Dunleavy U, Nicolson C, Robertson JS, Schild GC |
| Jazyk: |
angličtina |
| Zdroj: |
Vaccine [Vaccine] 2002 May 15; Vol. 20 Suppl 2, pp. S84-7. |
| DOI: |
10.1016/s0264-410x(02)00139-1 |
| Abstrakt: |
In response to the pandemic warning provided by the highly pathogenic H5N1 influenza virus infections in Hong Kong, there were world-wide attempts to develop vaccines. Three strategies were followed and although each was associated with some success, there were also some problems. Pre-clinical vaccine efficacy results are presented from one such strategy, that of using an apathogenic H5N3 avian strain for vaccine production. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect